The estimated Net Worth of Rhonda Germany Ballintyn is at least $549 mil dollars as of 8 August 2019. Ms. Ballintyn owns over 4,878 units of Integra Lifesciences Corp stock worth over $209,334 and over the last 8 years she sold IART stock worth over $0. In addition, she makes $339,625 as Independent Director at Integra Lifesciences Corp.
Rhonda has made over 2 trades of the Integra Lifesciences Corp stock since 2019, according to the Form 4 filled with the SEC. Most recently she bought 4,878 units of IART stock worth $100,682 on 8 August 2019.
The largest trade she's ever made was buying 4,878 units of Integra Lifesciences Corp stock on 8 August 2019 worth over $100,682. On average, Rhonda trades about 324 units every 7 days since 2017. As of 8 August 2019 she still owns at least 11,894 units of Integra Lifesciences Corp stock.
You can see the complete history of Ms. Ballintyn stock trades at the bottom of the page.
Rhonda Germany Ballintyn serves as Independent Director of the Company. Ms. Germany Ballintyn formerly served as corporate vice president, chief strategy and marketing officer for Honeywell International, Inc. Prior to that, she served as vice president, partner, board member and member of the board’s personnel committee for Booz Allen Hamilton. In addition, she held various management roles with Union Carbide and Chem Systems Inc. Ms. Germany Ballintyn serves on the board of directors of Univar, Inc. where she is a member of the audit committee and the nominating and corporate governance committee. She also serves on the board of directors for Aegion Corporation, a gas and water company, where she serves on the nominating and corporate governance committee and the compensation committee, Hypertherm, Inc., a private manufacturer of industrial cutting solutions, Zapata Computing, a venture start-up quantum backed computing company, and UMGC Ventures, a nonprofit holding company created by the University System of Maryland Board of Regents. She earned a Bachelor’s degree in chemical engineering from the University of Michigan and an MBA in finance from the University of Connecticut.
As the Independent Director of Integra Lifesciences Corp, the total compensation of Rhonda Ballintyn at Integra Lifesciences Corp is $339,625. There are 9 executives at Integra Lifesciences Corp getting paid more, with Peter Arduini having the highest compensation of $7,859,420.
Rhonda Ballintyn is 64, she's been the Independent Director of Integra Lifesciences Corp since 2019. There are 4 older and 17 younger executives at Integra Lifesciences Corp. The oldest executive at Integra Lifesciences Holdings Corp is Dr. Richard E. Caruso, 78, who is the Founder and Chairman Emeritus.
Rhonda's mailing address filed with the SEC is C/O UNIVAR SOLUTIONS INC., 3075 HIGHLAND PARKWAY, SUITE 200, DOWNERS GROVE, IL, 60515.
Over the last 22 years, insiders at Integra Lifesciences Corp have traded over $397,927,161 worth of Integra Lifesciences Corp stock and bought 132,879 units worth $4,504,827 . The most active insiders traders include Neal Moszkowski, Stuart Essig y George Soros. On average, Integra Lifesciences Corp executives and independent directors trade stock every 19 days with the average trade being worth of $668,131. The most recent stock trade was executed by Jeffrey Mosebrook on 19 August 2024, trading 1,191 units of IART stock currently worth $25,702.
integra lifesciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. integra offers innovative solutions in orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery. integra's orthopedic products include devices and implants for spine, foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, and wound repair. integra is a leader in neurosurgery, offering a broad portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. in the united states, integra is a leading provider of surgical instruments to hospitals, surgery centers and alternate care sites, including physician and dental offices. founded in 1989 integra is headquartered in plainsboro, new jersey and has over 3,500 employees worldwide. integra's common stock is li
Integra Lifesciences Corp executives and other stock owners filed with the SEC include: